Loading clinical trials...
Loading clinical trials...
PET/CT-Derived Hepatopulmonary Shunt Fraction Following Yttrium-90 Radioembolization
Conditions
Interventions
positron emission tomography
computed tomography
Locations
1
United States
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
Start Date
January 30, 2014
Primary Completion Date
July 1, 2015
Completion Date
December 31, 2026
Last Updated
April 11, 2025
NCT04143516
NCT06362395
NCT06787183
NCT07281924
NCT07225036
NCT07177742
Lead Sponsor
University of Cincinnati
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions